Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 11.05.2026 1 Am J Gastroenterol 1 Biochem Biophys Res Commun 2 BMC Cancer 10 BMC Gastroenterol 4 Clin Res Hepatol Gastroenterol 2 Dig Dis Sci 1 Eur Radiol 1 Gut 1 Hepatology 3 J Hepatol 1 Oncogene 3 PLoS One 2 Radiology 4 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. HATIPOGLU D, Kiran A, Mahmud N
   Guidelines in Practice: Preoperative Risk Assessment and Management in Patients with Cirrhosis.
   Am J Gastroenterol. 2026 May 5. doi: 10.14309/ajg.0000000000004043.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

2. KIM Y, Ham B, Kim Y, Jung BH, et al
   Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells.
   Biochem Biophys Res Commun. 2026;821:153785.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. WANG H, Chen D, Liu Z, Zhao X, et al
   Evaluation of the abscopal-like effect of radioimmunotherapy on sentinel lymph nodes in H22 hepatocellular carcinoma via dynamic lymphography.
   BMC Cancer. 2026 May 7. doi: 10.1186/s12885-026-16140.
   PubMed         Abstract available
   
   
4. LI Y, Lv S, Wang Y
   Predicting prognosis and drug sensitivity in patients with hepatocellular carcinoma using an lncRNA signature associated with cuproptosis.
   BMC Cancer. 2026 May 4. doi: 10.1186/s12885-026-16132.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. ZHAO H, Dong L, Lin G, Jia S, et al
   Effect of human albumin infusion on inflammation, oxidative stress, and prognosis in decompensated cirrhosis: a prospective cohort study with a meta-analysis.
   BMC Gastroenterol. 2026 May 1. doi: 10.1186/s12876-026-04866.
   PubMed         Abstract available
   
   
6. ZHANG L, Li L, Du X, Pang S, et al
   Integrated routine laboratory indices for risk stratification in HBV-related cirrhosis: a real-world study.
   BMC Gastroenterol. 2026 May 1. doi: 10.1186/s12876-026-04869.
   PubMed         Abstract available
   
   
7. SHINKAI K, Sakamori R, Yamada R, Tahata Y, et al
   Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliteration.
   BMC Gastroenterol. 2026 May 2. doi: 10.1186/s12876-026-04893.
   PubMed         Abstract available
   
   
8. LIANG B, Shi H, Zeng Q, Tie X, et al
   Laparoscopic partial hepatectomy for primary hepatic PEComa: a case report.
   BMC Gastroenterol. 2026 May 2. doi: 10.1186/s12876-026-04884.
   PubMed         Abstract available
   
   
9. ZHOU J, Zhang B, Niu J
   The value of the serum cytokine-to-immune ratio model in predicting the progression-free survival after interventional therapy for hepatocellular carcinoma.
   BMC Gastroenterol. 2026 May 6. doi: 10.1186/s12876-026-04894.
   PubMed         Abstract available
   
   
10. LIU J, He S, Zhang H, Mai H, et al
    Machine learning-driven clinical decision support for liver cirrhosis: a gut microbiome-based web prediction model with explainable AI integration.
    BMC Gastroenterol. 2026 May 6. doi: 10.1186/s12876-026-04890.
    PubMed         Abstract available
    
    
11. PHAM GA, Bui TN, Bui TC, Cao MT, et al
    Integrated clinicopathological model versus TNM for predicting survival in resected hepatocellular carcinoma: a retrospective cohort study.
    BMC Gastroenterol. 2026 May 7. doi: 10.1186/s12876-026-04895.
    PubMed         Abstract available
    
    
12. LIAO J, Wang M, Du M, Wang Y, et al
    Association between the blood urea nitrogen to albumin ratio and all-cause mortality in critically ill patients with liver cirrhosis.
    BMC Gastroenterol. 2026 May 6. doi: 10.1186/s12876-026-04887.
    PubMed         Abstract available
    
    
13. KIM SH, Lee R, Tak E, Kim KH, et al
    Circulating miR-184 and miR-206 as predictive biomarkers for early recurrence in HBV-related hepatocellular carcinoma: a prospective study.
    BMC Gastroenterol. 2026 May 6. doi: 10.1186/s12876-026-04871.
    PubMed         Abstract available
    
    
14. DIBOS M, Wossnig M, Wunderlich S, Schmid RM, et al
    Risk of intracranial hemorrhage in critically ill ACLF patients: a retrospective single center cohort study.
    BMC Gastroenterol. 2026;26:281.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

15. MYLENE S, Funda Y, Faouzi S, Ilias K, et al
    The late-onset of veno-occlusive disease after liver transplantation is associated with poorer graft survival.
    Clin Res Hepatol Gastroenterol. 2026 Mar 24:102811.
    PubMed         Abstract available
    
    
16. CAO Z, Chen Z, Zhang Y, Tan Y, et al
    Targeting metabolic dysregulation in HCC: Development and validation of a dual-biomarker diagnostic model integrating ADH1C and BHMT.
    Clin Res Hepatol Gastroenterol. 2026;50:102814.
    PubMed         Abstract available
    
    
17. HOEMANN BL, Kollef MH, Vijayan A, Michelson AP, et al
    Predictors of in-hospital mortality among patients with cirrhosis and renal replacement therapy in the ICU: a retrospective cohort study.
    Clin Res Hepatol Gastroenterol. 2026 Apr 1:102821.
    PubMed         Abstract available
    
    
18. ZHANG H, Quan X, Wu H
    POEMS syndrome presenting as Porto-sinusoidal vascular disease: A case report.
    Clin Res Hepatol Gastroenterol. 2026;50:102826.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

19. FAR AT, Ayati A, Guillot J, Azzam S, et al
    Large Language Models can Identify the Presence of MASH and Extract VCTE Measurements from Unstructured Documentation.
    Dig Dis Sci. 2026;71:1505-1511.
    PubMed         Abstract available
    
    
20. CHAN SY, Yeo YH, Kim H, Delk M, et al
    Trends in Concurrent Psychiatric Comorbidities in Alcohol-Associated Liver Disease: A Nationwide Study from 2015-2023.
    Dig Dis Sci. 2026;71:1493-1504.
    PubMed         Abstract available
    
    

    
    Eur Radiol

21. FERRAIOLI G
    Commentary: Diagnostic performance of ultrasound-derived fat fraction for grading hepatic steatosis in patients with chronic liver diseases-a multicenter study.
    Eur Radiol. 2026 May 6. doi: 10.1007/s00330-026-12611.
    PubMed        
    
    

    
    Gut

22. CUBERO FJ, Macias RIR
    Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinoma.
    Gut. 2026 May 4:gutjnl-2026-338744. doi: 10.1136/gutjnl-2026-338744.
    PubMed        
    
    

    
    Hepatology

23. AOE K, Tada T, Hiraoka A, Matono T, et al
    Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study.
    Hepatology. 2026 May 6. doi: 10.1097/HEP.0000000000001781.
    PubMed         Abstract available
    
    

    
    J Hepatol

24. FONDEVILA MF, Schnabl B
    Letter in response to Hepatic CTSB is Kupffer cell-enriched, whereas disease-state stratification is more strongly captured by endotoxin/TLR4 programmes.
    J Hepatol. 2026 Apr 29:S0168-8278(26)00230-8. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
25. WANG P, Li H, Chen Y, Zhong L, et al
    Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor-based downstaging for hepatocellular carcinoma.
    J Hepatol. 2026 May 2:S0168-8278(26)00224-2. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
26. KOCHEISE L, Waldmann M, Salie H, Ghadban T, et al
    Extended Longitudinal Validation of Serum Procalcitonin as a Biomarker for Fibrolamellar Hepatocellular Carcinoma.
    J Hepatol. 2026 May 5:S0168-8278(26)00265-5. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    

    
    Oncogene

27. LI Y, Zheng C, Liang Y, Liu Y, et al
    S100A6 promotes liver metastasis by activating FGFR3 signaling in BAP1-deficient uveal melanoma.
    Oncogene. 2026 Apr 4. doi: 10.1038/s41388-026-03766.
    PubMed         Abstract available
    
    

    
    PLoS One

28. NISHIOKA C, Tahata Y, Maesaka K, Kai M, et al
    Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
    PLoS One. 2026;21:e0341395.
    PubMed         Abstract available
    
    
29. ARRAMRAK K, Witayavanitkul N, Chayanupatkul M, Wanpiyarat N, et al
    Calcitriol attenuates diethylnitrosamine-induced hepatic fibrosis in rats by reducing oxidative stress and fibrogenic mediators.
    PLoS One. 2026;21:e0347908.
    PubMed         Abstract available
    
    
30. GORLOV IP, Gorlova OY, Thrift AP
    Differences in gene expression may contribute to the racial differences in the risk of MASLD.
    PLoS One. 2026;21:e0345383.
    PubMed         Abstract available
    
    

    
    Radiology

31. BERMAN ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, et al
    Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.
    Radiology. 2026;319:e251923.
    PubMed         Abstract available
    
    
32. BRUNSING RL, Syed AB, Hargreaves BA, Ennis DB, et al
    Diffusion-weighted Imaging of the Liver: Primed for New Business.
    Radiology. 2026;319:e250157.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

33. MAHMUT D, Gouon-Evans V
    Endothelial Cell Therapy for the Acute and Chronic Liver Disease.
    Semin Liver Dis. 2026;46:77-88.
    PubMed         Abstract available
    
    
34. ISERTE G, Llarch N, Moon AM, Reig M, et al
    Optimizing Liver Cancer Care Through BCLC Principles.
    Semin Liver Dis. 2026;46:23-30.
    PubMed         Abstract available
    
    
35. WEINFURTNER K, Amin R, Skuli N, Gade TP, et al
    Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.
    Semin Liver Dis. 2026;46:51-62.
    PubMed         Abstract available
    
    
36. FRANZ A, Shay H, Kirpich I, McClain CJ, et al
    Nutrition and Liver Disease.
    Semin Liver Dis. 2026;46:63-76.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum